View Larger
Thomas Charles Merigan M.D.
Academic Appointments
- Emeritus Faculty, Acad Council, Medicine - Infectious Diseases
Key Documents
Contact Information
- Academic Offices
Personal Information Email
Professional Overview
Honors and Awards
- Endowed Thomas C and Joan M Merigan chair in Medicine, Stanford University (2008)
- Festschift with publication(J. of Inf. Dis. 162,Supp. 1,2006), Sponsored by former students (2004)
- George E. and Lucy Becker Professor of Medicine, Stanford University (!980-2006)
- One of "250 Most Highly Cited Scientists in Clinical Medicine over 20 years,1983-2001", Institute of Scientific Information (2004)
- Elected to Honorary Membership, International Society for Interferon and Cytokine Research (2001)
- Establishment of Annual Thomas C. Merigan, Jr. Endowed Lectureship in I.D., Stanford Medical School, Funded by Friends and Former Fellows (1994)
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
I am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
Publications
- Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance. Viruses. 2012; (8): 1212-34
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med. 2009; (3): 285-92
- Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006; (4): 426-34
- Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics. 2006; (11): 837-45
- "Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target. Structure. 2005; (12): 1887-95
- Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection. Clin Infect Dis. 2005; (2): 236-42
Help